REXULTI- brexpiprazole tablet

Drug facts, interactions, warnings, dosage for Rexulti by manufactured/distributed by Otsuka America Pharmaceutical, Inc., Otsuka Pharmaceutical Co Ltd, Sharp Corporation, Eurofins Lancaster Laboratories, Boston Analytical Inc, Legacy Pharmaceutical Packaging, LLC

Table 2 from Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder.

REXULTI® (brexpiprazole), MDD

Otsuka America Pharmaceutical 59148003813 - McKesson Medical-Surgical

What you need to know about Rexulti (Brexpiprazole)

Otsuka America Pharmaceutical 59148003613 - McKesson Medical-Surgical

Rexulti (Brexpiprazole) for the Treatment of Major Depressive Disorder (MDD) and Schizophrenia - Clinical Trials Arena

USFDA approves Lupin's Brexpiprazole tablets for schizophrenia and depression, ET HealthWorld

Rexulti (Brexpiprazole) how to use: Uses, Dosage, Side Effects, Contraindications

Rexulti healthdirect